Recently, hydrogen sulfide (H 2 S) has been identified as a potential therapy for ED. However, a thorough understanding of its molecular mechanisms of action would be essential to develop H 2 S as a new therapy for ED. In this study, the effect of H 2 S on nitric oxide (NO) production, especially through the expression of constitutive nitric oxide synthase (NOS) isoforms-endothelial NOS (eNOS) and neuronal NOS (nNOS) in rat corpus cavernosum (CC) were explored. Real-time PCR studies subsequent to in vitro treatment of sodium hydrosulfide hydrate (NaHS), a stable H 2 S donor, showed increases in eNOS but not nNOS mRNA. Western blot studies confirmed that the exogenously applied NaHS increased eNOS but not nNOS protein expression in the rat CC. Furthermore, NaHS did not alter the expressed amounts of Caveolin-1 (CAV-1), a dominant inhibitory interaction partner of eNOS, in these tissues. Not surprisingly, NaHS also enhanced the NO production in eNOS-associated membrane fraction of rat CC. Taken together, we ascertain that H 2 S could exert its proerectile effects by augmenting NO pathway. It appears that H 2 S would be particularly useful in improving the clinical outcome of ED patients, whose erectile impairment is due to an inherent attenuation of the endothelial NO formation in the cavernosum.
INTRODUCTION
Hydrogen sulfide (H 2 S), which is well known as a pungent and toxic gas, is identified to be a gasotransmitter endowed with physiological and pathological functions. 1, 2 Much as another gasotransmitter,nitric oxide (NO), relaxes the vascular smooth muscle cells and causes the blood vessel to dilate, 3, 4 where it is mainly synthesized from L-cysteine by Cystathionine-g-lyase. 5 Considering that male sexual function is intrinsically vasodilatation-dependent, it is not surprising that H 2 S promoted erectile capacity through relaxation of corpus cavernosum (CC) tissues (highly vascularized smooth muscles); a pilot in vivo study in primates demonstrated the proerectile effect of H 2 S injection into the cavernosum. 6 In addition, in vitro studies on rabbit and human CC tissues have confirmed the physiological nature of H 2 Smediated relaxation, 6, 7 whereas molecular and biochemical studies have also documented the presence of Cystathionine-bsynthase (another dominant H 2 S-producing enzyme in mammalians), together with Cystathionine-g-lyase as catalysts for the endogenous production of H 2 S. [6] [7] [8] These findings reinforce the intrinsic involvement of H 2 S in the male sexual function.
With the increasing expectation for the usefulness of H 2 S in ED as a new supplemental therapy, there is an urgent need to fully understand the complex molecular mechanisms of its function. Activation of ATP-sensitive potassium (K ATP ) channel in vascular smooth muscle cells potentially underlies the acute vasorelaxation induced by H 2 S. 5, 9 Exogenous and endogenous H 2 S stimulated neovascularization in vitro and in vivo on a prolonged exposure (48 h) as evidenced by an accelerated proliferation and migration of vascular endothelial cells and increased vascular length. 10 However, the action of H 2 S on the NO-cyclic guanosine monophosphate pathway, the final common mediator of penile erection, is still uninvestigated. NO is endogenously produced by nitric oxide synthases (NOS) through the metabolism of L-arginine, and has physiological functions in smooth muscle relaxation. 11 As the terms suggest, endothelial NOS (eNOS) is exclusively present in the vascular endothelium, whereas neuronal NOS (nNOS) localizes in the neuronal cells of CC. 12 In some types of organic ED such as the type 2 diabetes-related ED, a decreased NO production has been observed, which may account for the resistance to the currently available drugs (PDE5 inhibitors). 13, 14 The continuing need to identify effective therapeutic approaches for diabetic and/or vasculogenic ED, together with the paucity of evidence on the underlying molecular mechanisms of H 2 Smediated sexual actions, prompted us to further investigate its role on NO production, particularly on the expression and activity of constitutive NOS isoforms-eNOS and nNOS.
MATERIALS AND METHODS

Animal and chemical
research. Prior to experimental use, the animals were acclimatized in the animal holding unit for at least 7 days, with 12 h light À dark cycle and free access to chow and water at all times.
Sodium hydrosulfide (NaHS) and all other chemicals were of analytical quality and obtained from Sigma-Aldrich (Munich, Germany). A freshly prepared solution of NaHS was used as a stable donor (when dissolved in water, NaHS rapidly releases the hydrosulfide anion, which enters into equilibrium with H þ to yield H 2 S). All oligonucleotide primers were purchased from Sigma, Singapore.
Tissue preparation and culture
For the isolation of rat CC tissues, male Sprague À Dawley rats were euthanized and the erectile tissue dissected out carefully from surrounding structures and cleaned in Dulbecco's modified Eagle's medium (DMEM, Sigma). The test samples were cut into small pieces (1-2 mm 2 ) and cultured for indicated times in DMEM, supplemented with antibiotics/ antimycotics at 37 1C and in the presence or absence of NaHS (up to a concentration of 1 mM, which has not been shown to induce any significant loss of cell viability). 15 RNA extraction, reverse transcription and real-time quantitative PCR Total RNA of each CC tissue was isolated using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) or RNeasy fibrous tissue mini kit (Qiagen, Hilden, Germany) following the manufacturer's protocol. Subsequently, the RNA concentrations and quality were measured using the NanoDrop (Thermo Scientific, Middletown, VA, USA). For the analysis of real-time quantitative PCR (qPCR), DNase I-treated total RNA from rat CC tissues was reverse transcribed using SuperScript III reverse transcription kit (Invitrogen).
Real-time qPCRs were carried out using SYBR Green PCR master mix on the ABI PRISM 7300 Real-time PCR system (Applied Biosystems, Warrington, Cheshire, UK). Briefly, the reaction was performed in triplicate in 96-well optical plates using 2 ml of complementary DNA, 1 power SYBR Green (Applied Biosystems, USA) and 250 nm concentration of each primer in a final volume of 20 ml. Thermocycling conditions comprised of an initial holding step at 95 1C for 10 min and 45 cycles of 95 1C for 15 s and 60 1C for 60 s. To exclude nonspecific amplification and/or the formation of primer dimers, control reactions were performed in the absence of target complementary DNA. The data were normalized to the expression of the rat b-actin gene. Specific primers used for rat eNOS, nNOS, Caveolin-1 (CAV-1) and b-actin are listed in Supplementary Table 1 . The PCR products were also visualized by GelRed (Biotium, Hayward, CA, USA), staining on a 1.8% agarose gel to confirm the presence of the single, specific band.
Western blot
The membrane and cytosolic protein fractions from rat CC tissues were isolated using Qproteome Cell compartment kit (Qiagen, Germany) or PromoKine membrane protein extraction kit (PromoCell, Heidelberg, Germany), following the manufacturer's protocol. The cytosolic protein fractions were used to evaluate nNOS protein expression and the membrane protein fractions for membrane-associated eNOS and CAV-1. All fractions were aliquoted and immediately frozen at À 80 1C until analysis. Protein concentration of the samples was determined by the Bradford assay (Sigma, Germany).
For analysis of protein expression, 20 mg per lane of membrane or cytosolic protein was electrophoresed through 10% SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membranes. These membranes were incubated in blocking buffer containing 1 Â phosphate buffered saline and 0.1% Tween 20 plus 5% dry milk for 1 h at room temperature, followed by an overnight incubation at 4 1C with the primary antibodies (monoclonal anti-eNOS antibody (1:200, BD Biosciences, San Diego, CA, USA), polyclonal anti-nNOS antibody (1:100, Santa Cruz, Santa Cruz, CA, USA), monoclonal anti-CAV-1 antibody (1:20 000, Cell Signaling, Danvers, MA, USA or monoclonal anti-b-actin antibody (1:1000, Cell Signaling)). The membranes were then extensively washed in phosphate buffered saline and 0.1% Tween 20, followed by incubation in secondary antibody (goat anti-mouse or goat anti-rabbit immunoglobin G (H þ L)-horseradish peroxidase conjugate at a dilution of 1:1000) for 1 h at room temperature. Blots were developed using enhanced chemiluminescence (Thermo Scientific, USA), according to the manufacturer's recommendations.
NOS enzyme activity assay NOS activity was determined by EnzyChrom Nitric Oxide synthase assay kit (Bioassay Systems, Hayward, CA, USA). In brief, two steps were involved: a NOS reaction step, during which NO was produced, followed by an NO detection step. As the NO generated by the NOS was rapidly oxidized to nitrite and nitrate, the NO production was measured following the reduction of nitrate to nitrite using an improved Griess method. 16 
Data analysis
The amplification curve of qPCR was collected and analyzed with DDC t methods for relative quantification of mRNAs. Western films were scanned and the density of target protein bands quantified by multiplying the mean optical density with the band area above background using Image J software (National Institutes of Health, Bethesda, MD, USA). Expression levels of eNOS, nNOS and CAV-1 were normalized to b-actin and described as fold-difference compared with non-treated controls. All of the statistical comparisons were made using Student's t-test and two-tailed analyses. P-valueso0.05 were considered to be statistically significant.
RESULTS
NaHS treatment-induced eNOS mRNA and protein expression
To determine whether a short-or medium-term treatment of NaHS regulated eNOS mRNA abundance in the cavernosum, cultured CC tissues were stimulated with 1 mM NaHS for 2, 4 and 6 h and RNA harvested for real-time reverse transcription PCR analyses. As shown in Figure 1a , NaHS enhanced eNOS mRNA expression in a time-dependent manner, with a maximum increase of B4-fold observed at the 6-h time point (Po0.001). The eNOS mRNA level was indeed elevated as early as 4 h after treatment, when around 1.6-fold increase was detected (Po0.05). Notably, the lower concentrations of NaHS including 500 nM did not influence eNOS mRNA expression in the same period, when the preliminary titration was performed.
In studies to estimate whether H 2 S promoted eNOS protein expression in CC tissues alongside the transcriptional level, the samples were processed in 1 mM NaHS-dissolved DMEM for 6 h because NaHS appeared to elevate eNOS expression in a timedependent manner. As B80% eNOS is located on the cell membrane, the membrane protein fractions were isolated, following treatment to measure their expression by western blot analysis. As shown in Figure 1b , NaHS incubation markedly increased the expression level of membrane-associated eNOS compared with controls (tissues soaked in plain DMEM). Density analysis, after adjusting with internal control of b-actin, showed about 50% increase of eNOS protein expression in the membrane fractions after NaHS treatment (Po0.05) (Figure 1c ). Taken together, these results indicate that NaHS induced eNOS transcription and subsequent increase in protein levels.
NaHS treatment did not significantly alter CAV-1 expression Caveolins are B22 kDa proteins integrally linked to membranes with membrane-spanning domains and reversible post-translational triple C-terminal palmitoylation.
17 CAV-1 has been shown to be abundant in endothelial cells and interact directly with eNOS. Caveolin tonically inhibits eNOS in quiescent cells both by sterical blocking of the calmodulin-binding site in eNOS as well as by impeding the signaling of caveolae-targeted receptors that transduce eNOS-stimulatory signals. 18 To examine if H 2 S may regulate eNOS activity through influencing CAV-1 expression, membrane protein portion of tissue lysates were prepared and CAV-1 expression was determined by western blot and qPCR. As shown in Figures 2b and c , NaHS treatment for 6 h did not significantly alter CAV-1 protein expression compared with non-treated control. Meanwhile, there was also no statistical difference for CAV-1 mRNA levels following 6 h of treatment with NaHS (Figure 2a) , which is similar to the results obtained from 2 or 4 h of incubation (data not shown). NaHS treatment did not regulate nNOS expression nNOS is another dominant constitutive NOS in CC. To investigate whether H 2 S has a pharmacological significance on the expression of nNOS, we looked at the mRNA and protein expression levels of nNOS after NaHS treatment. Rat CC tissues were incubated with 1 mM NaHS for 6 h and the cytosolic proteins were extracted to evaluate nNOS protein expression (as nNOS is dominantly present in the cytosolic fraction). However, in contrast to eNOS, endogenous nNOS protein was not inducible with NaHS treatment. The expression of nNOS protein was not significantly changed after NaHS treatment (Figures 3b and c) . In addition, the amount of nNOS mRNA was also measured using qPCR. As shown in Figure 3a , nNOS mRNA levels from NaHS-treated CC remained consistent with control values at the time point of 6 h, which is similar to the results obtained from 2 and 4 h of incubation (data not shown). Taken together, these findings indicate that NaHS did not induce nNOS expression at the transcriptional or translational levels in the rat cavernosum.
NOS activity in membrane proteins of CC was enhanced after NaHS treatment In accordance with eNOS protein content, the activity of NOS was also increased in the extracted membrane proteins of the rat CC treated with 1 mM NaHS for 6 h (Figure 4 ). The NOS activity was measured by NO production from L-arginine. Under the assay conditions (pH 7.5 and 37 1C), the NO production, normalized to CC tissues were isolated from adult rat and treated with or without 1 mM of NaHS for 6 h, and nNOS mRNA expression adjusted by bactin was examined by real-time quantitative PCR analysis (N ¼ 5). (b) Regulation of nNOS protein expression by NaHS treatment in rat CC tissues. Rat CC tissues were treated with or without 1 mM NaHS in Dulbecco's modified Eagle's medium for 6 h. The cytosolic nNOS protein level was determined by western blot analysis using a specific antibody directed against nNOS (upper panels). The same membrane was reprobed with an antibody directed against b-actin as a control for equal protein loading (lower panels). The ratios of nNOS to b-actin illustrated by mean ± s.e.m. from different experiments are shown in the bar graph (c) (N ¼ 5).
membrane À protein concentrations, significantly increased by more than five folds after NaHS pretreatment (Po0.001), indicating that H 2 S could augment the eNOS activity in the tested samples.
DISCUSSION
In this study, we attempted to delineate the effect of H 2 S on NO synthesis in the CC and its underlying mechanism. Corporal NO synthesis is much important in the maintenance of penile vascular tone and attenuated NO production is observed in different types of organic ED. The results demonstrate that H 2 S could upregulate NO synthesis in cavernosal tissues isolated from rats. Together, the observed data identifies a physiological mechanism for H 2 S in modulating NO production by inducing eNOS protein expression. Our findings suggest that H 2 S may be a potential therapy for ED, particularly when the impairment is due to attenuation of endothelium-derived NO formation in the cavernosum. 14, 19, 20 For instance, in diabetes-related ED which shows resistance to routine treatment with PDE5 inhibitors and necessitates more-invasive approaches (including intracavernosal injection therapy), decreased NO production has been a hallmark feature. Similarly in cases of vasculogenic ED, an activated RhoA/Rho kinase pathway highly suppressed eNOS expression in the endothelial cells. 21 Herein, our findings suggest that H 2 S mediators may be useful either alone or in combination with PDE5 inhibitors to improve the clinical outcome of ED of vascular origin. Notably, the value of this therapeutic modality needs to be carefully evaluated in situations where the suppression of eNOS pathway results from a functional or apoptotic loss of endothelial cells (for example, long-term diabetes). Further in vivo studies to estimate the level of improvement of erectile function as in diabetic animal models after exogenous treatment of H 2 S would also be necessary to reiterate our hypothesis. Meanwhile, as shown in this study, the effect of H 2 S in enhancing eNOS mRNA expression following 4-6 h of treatment, suggests that this mechanism is unlikely to be involved in the rapid relaxant effect of H 2 S. Furthermore, an acute administration of H 2 S has been shown to cause an immediate and full relaxation of the vascular smooth muscle tone, in the absence of intact endothelium. 7, 10 It may be argued that the incubation concentration of 1 mM for NaHS used in this study far exceeded its physiological level and is therefore, likely to suprapharmacological. Under normal conditions, H 2 S concentration ranges from 20 to 100 mM in plasma and is around 2.5 nM per mg of protein in the cavernosum. It follows that there will be a need to evaluate the possible adverse effect of this dosage administration using a suitable animal model. At the same time, it may be worthwhile to investigate alternative or targeted pharmacotherapy such as an intracavernosal injection to bypass effects of a high systemic administration of the NaHS dosage form.
Endothelial NO generated by eNOS is an important mediator of erectile function through its ability to induce vasodilation and to inhibit vasoconstriction. 21, 22 The regulation of eNOS activity in the CC has been widely investigated. In our study, it was found that H 2 S could stimulate both eNOS mRNA and protein expression in the cavernosum. Indeed, the complex regulation of eNOS in endothelial cells has been shown to occur at multiple stages. For instance, the eNOS mRNA levels are controlled at the transcriptional as well as post-transcriptional phases, and epigenetic mechanisms appear to modulate eNOS expression in a tissue-specific manner. 11 In quiescent endothelial cells, eNOS is specifically targeted to small invaginations of the plasmalemma called caveolae, which is defined by the presence of a scaffolding protein, Caveolin. Although eNOS enzyme reversibly associates with a diverse family of protein partners to regulate its sub-cellular localization, catalytic function and biological activity, CAV-1 has been shown to interact directly with eNOS and inhibit its activity in quiescent cells. 18 From the current study (Figures 1 and 2 ), it appears that H 2 S modulated eNOS activity directly by enhancing its expression but not through suppression of its inhibitory partner, CAV-1.
Studies have shown that administered H 2 S promoted neovascularization in a long-term manner. 10, 23 Treatment of vascular endothelial cells or chorioallantoic membranes with H 2 S for 48 h also increased cellular proliferation, capillary morphogenesis and vascular length. However, this seems to be an unlikely mechanism for the enhanced expression of eNOS in our study because the incubation time of 6 h is unlikely to be sufficient for the above mentioned effects. Similar to eNOS, CAV-1 is dominantly located in endothelial cells; 18 however, its expression remained unaltered after NaHS treatment (Figure 2 ), which also supports our view that the increased eNOS is independent of endothelial proliferation.
Taken together, our results confirm that H 2 S' proerectile effects are due in part to enhanced expression of eNOS and augmented NO pathway in the CC, thereby reinforcing the expectation of H 2 S as a supplemental treatment for ED in refractory cases. Figure 4 . Hydrogen sulfide elevated nitric oxide synthase (NOS) activity in the membrane proteins from corpus cavernosum (CC). Bar graph shows the NOS activity measured in extracted membrane proteins from rat CC treated with or without 1 mM sodium hydrosulfide hydrate (NaHS) in Dulbecco's modified Eagle's medium for 6 h. The specific activity of the enzyme was measured by nitric oxide production from L-arginine. The results are expressed in the fold change of nitric oxide production under the assay conditions (pH 7.5 and 37 1C) after normalizing with membrane-protein concentrations. Data are mean ± s.e.m. and the results are significant at Po0.001 level (***) (N ¼ 6).
